• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 42075060-120
Device Problems Break (1069); Stretched (1601); Device Damaged by Another Device (2915)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/05/2021
Event Type  Injury  
Manufacturer Narrative
Unique device identifier (udi#): in the absence of a reported part and lot numbers, the udi cannot be calculated.Implant date estimated.The stent remains in patient.The device will not be returned for evaluation.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported at the end of (b)(6) an unspecified supera self-expanding stent was deployed in the common femoral artery.The stent ended distally just above the origin of the superficial femoral artery (sfa)/profunda.On (b)(6) 2021, the patient returned for intervention in the popliteal artery.An ultrasound-guided antegrade puncture was performed through the struts of the deployed supera stent with a 6f sheath.After puncturing and probably by introducing the sheath, it was found that the distal part of the deployed stent had elongated and extended into the proximal part of the sfa.Additionally, a small piece of supera wire had become loose from the distal part of the stent.This proximal part of the sfa, with the extended part of the deployed supera stent, gave a messy image after imaging by iodine contrast.An unspecified absolute pro self-expanding stent was placed from the origins to beyond the extended part of the deployed supera to include the partially detached piece of the supera stent.Good results were achieved.There was no clinically significant delay in the procedure.No additional information was provided.
 
Event Description
Additional information: it was reported the 7.5x60mm supera self-expanding stent was deployed on (b)(6) 2021 in the common femoral artery (cfa).No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other similar incidents from this lot.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that interaction as the deployed supera stent was punctured and the 6f sheath was introduced through the puncture resulted in the reported device damaged by another device.Interaction/manipulation of devices resulted in the reported supera stent damages (stretched, break).The treatment appears to be related to the operational context of the procedure as an unspecified absolute pro self-expanding stent was placed from the origins to beyond the extended part of the deployed supera to include the partially detached piece of the supera stent.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key12259477
MDR Text Key264508584
Report Number2024168-2021-06700
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 08/30/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/02/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2023
Device Catalogue Number42075060-120
Device Lot Number1022461
Was Device Available for Evaluation? No
Date Manufacturer Received08/09/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
SHEATH: 6F; SHEATH: 6F
Patient Outcome(s) Required Intervention;
-
-